レギオネラ肺炎に対するドキシサイクリン:症例シリーズとナラティブレビューを通じて治療の視野を広げること
M Gabriela Cabanilla1,2, Aileen C Scheibner2, Jorge R Mera1
1Division of Infectious Diseases, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
まとめ
ドキシサイクリン単独治療は,レジオネラ性肺炎の3つの症例で好ましい結果を示した. この抗生物質は,第一線治療が禁忌である場合に有効な代替薬である可能性がありますが,さらなる研究が必要です.
科学分野:
- 感染症
- 肺科
- 薬理学について
背景:
- レギオネラ性肺炎は,地域社会で発生する深刻な肺炎です.
- フロロロキノロンとマクロリドは標準的な治療法です
- ドキシサイクリンは,良好な薬動性と安全性を有する代替品です.
研究 の 目的:
- レジオネラ性肺炎に対するドキシサイクリン単独治療の評価
- 60日後の臨床結果と生存率を評価する.
- レジオネラ感染に対するドキシサイクリンに関する既存の文献をレビューする.
主な方法:
- ドキシサイクリンを投与した3人の入院患者のケースシリーズ
- 臨床改善,症状解消,生存の評価
- レジオネラに対するドキシサイクリンに関する包括的な文献レビュー (1980年−2025年).
主要な成果:
- 3人の患者全員の臨床改善が認められ,生存期間は60日でした.
- 文献のレビューでは,レジオネラ菌に対するドキシサイクリンの臨床データが限られていることが明らかになった.
- インビトロ研究では,ドキシサイクリンは,フッ素ヒノロンよりも細菌滅菌作用が少ないことが示唆されています.
結論:
- ドキシサイクリン単独治療は,これらのレギオネラ性肺炎の症例において陽性な結果を示した.
- ドキシサイクリンは,第一線治療の反対症状のある患者にとって,潜在的な代替薬です.
- レジオネラ性肺炎の治療におけるドキシサイクリンの決定的な役割を確立するには,さらなる研究が必要である.
さらに関連する動画
09:09High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
8.0K
08:34Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages
Published on: February 22, 2017
11.3K
関連する概念動画
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
39
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
39
01:26Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
01:28Pneumonia IV: Management
445
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
445
01:28Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
01:28Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
01:31Pulmonary Tuberculosis III
439
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
439